Cardiac tamponade primary prevention

Jump to navigation Jump to search

Cardiac tamponade Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiac Tamponade from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Cardiac tamponade primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Cardiac tamponade primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiac tamponade primary prevention

CDC on Cardiac tamponade primary prevention

Cardiac tamponade primary prevention in the news

Blogs on Cardiac tamponade primary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Cardiac tamponade primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]; Hafiz M. Ahmed, M.D.[3]

Overview

There are no established measures that specifically prevent all cases of cardiac tamponade. Primary prevention focuses on early recognition and appropriate management of conditions that may lead to clinically significant pericardial effusion, including inflammatory, infectious, malignant, traumatic, iatrogenic, and post-cardiac injury causes.

Primary Prevention

  • No universal preventive intervention is established for cardiac tamponade.
  • Prompt diagnosis and treatment of pericarditis after cardiac procedures is recommended because post-cardiac injury pericarditis may be underdiagnosed or misdiagnosed.
  • In patients at risk for post-cardiac injury pericarditis, anti-inflammatory prophylaxis such as colchicine may be considered, although supporting data are limited.
  • Patients with known or suspected pericardial effusion should be evaluated for hemodynamic impact, because the risk of tamponade depends on the rate of fluid accumulation as well as the amount of fluid.[1]

References

  1. ↑ Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA, Mardigyan V, Mukherjee M, Ordovas K, Vakamudi S, Wohlford GF. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2025;86(25):2691-2719. https://doi.org/10.1016/j.jacc.2025.05.023.

Template:WH Template:WS